ArticleLeukemia2005

Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model.

E Van Valckenborgh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.